ValueAct Holdings
13F Holdings and Portfolio Analysis
Jeffrey Ubben 2017 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
ValueAct Holdings Overview
ValueAct Holdings held 14 stocks in 2017 Q1, with total market value around $11.94B.
ValueAct Holdings's top five holdings in 2017 Q1: BAKER HUGHES INC 15.73%, TWENTY FIRST CENTY FOX INC CL B 14.19%, MICROSOFT CORP COM(MSFT) 12.69%, ALLIANCE DATA SYSTEMS CORP 12.25%, CBRE GROUP INC COMMON STOCK(CBRE) 12.20%.
- Portfolio Value
- $11.94B
- Current Holdings
- 14 stocks
- New / Increased
- 1 / 4
- Reduced / Exited
- 2 / 1
Current Holdings
| 1 | BAKER HUGHES INCCUSIP 057224107 | 1.88 | 15.73% | 31.41 +14.59% | $59.82 | - | $54.10 | +4.00 | 2.50 | +$0.18B+10.58% | Increased |
| 2 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 1.69 | 14.19% | 53.33 - | $31.78 | - | $32.28 | 0.00 | 3.00 | -$0.03B-1.54% | Held |
| 3 | MICROSOFT CORP COMMSFT | 1.52 | 12.69% | 23.01 -40.42% | $65.86 | $460.25 +598.83% | $52.80 | -15.61 | 4.00 | +$9.38B+771.64% | Reduced |
| 4 | ALLIANCE DATA SYSTEMS CORPCUSIP 018581108 | 1.46 | 12.25% | 5.88 +12.03% | $249.00 | - | $210.62 | +0.63 | 1.25 | +$0.23B+18.22% | Increased |
| 5 | CBRE GROUP INC COMMON STOCKCBRE | 1.46 | 12.20% | 41.87 - | $34.79 | $126.04 +262.29% | $25.16 | 0.00 | 4.00 | +$4.22B+400.85% | Held |
| 6 | WILLIS TOWERS WATSON PLC LTD SHSWLTW | 1.06 | 8.88% | 8.11 - | $130.89 | - | $118.96 | 0.00 | 1.25 | +$0.10B+10.03% | Held |
| 7 | MORGAN STANLEY COM NEWMS | 0.77 | 6.41% | 17.88 -33.52% | $42.84 | - | $39.82 | -9.02 | 1.00 | +$0.05B+7.59% | Reduced |
| 8 | BIOVERATIV INCCUSIP 09075E100 | 0.46 | 3.86% | 8.48 | $54.46 | - | $54.46 | +8.48 | 0.25 | $0.00B0.00% | New |
| 9 | SEAGATE TECHNOLOGY PLCCUSIP G7945M107 | 0.44 | 3.67% | 9.54 - | $45.93 | - | $34.09 | 0.00 | 1.00 | +$0.11B+34.74% | Held |
| 10 | ARMSTRONG WORLD INDUSTRIESAWI | 0.42 | 3.55% | 9.20 - | $46.05 | - | $56.42 | 0.00 | 3.00 | -$0.10B-18.38% | Held |
| 11 | TRINITY INDUSTRIES INCTRN | 0.41 | 3.46% | 15.58 - | $26.55 | - | $22.75 | 0.00 | 1.00 | +$0.06B+16.72% | Held |
| 12 | VALEANT PHARMACEUTICALS INTECUSIP 91911K102 | 0.20 | 1.66% | 18.00 +20.03% | $11.03 | - | $74.68 | +3.00 | 4.00 | -$1.15B-85.23% | Increased |
| 13 | NETSCOUT SYS INCCUSIP 64115T104 | 0.09 | 0.73% | 2.30 +39.82% | $37.95 | - | $33.34 | +0.66 | 0.50 | +$0.01B+13.84% | Increased |
| 14 | ARMSTRONG FLOORING INCCUSIP 04238R106 | 0.08 | 0.71% | 4.60 - | $18.42 | - | $16.95 | 0.00 | 1.00 | +$0.01B+8.67% | Held |
Showing 1-14 of 14
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2017 Q1.
| 1 | ALLISON TRANSMISSION HLDGS ICUSIP 01973R101 | 10.53 | 3.50 | $27.35 | $33.69 | +$0.07B+23.17% |
Showing 1-1 of 1
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.